Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TAZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,208
Award facts
- Contract value 100% obligated
- $12,208.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $12,208.26 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Gemtesa 75 mg tablets (90-count). This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which holds the parent IDC with the Defense Logistics Agency. The DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Gemtesa is a prescription medication used in the treatment of overactive bladder, reflecting the type of specialized pharmaceutical commodities routinely procured through this contract vehicle to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3TAZ?
SPE2DR26F3TAZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F3TAZ worth?
The government has obligated $12,208 on SPE2DR26F3TAZ.
Is contract SPE2DR26F3TAZ an order under another contract?
Yes. SPE2DR26F3TAZ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TAZ competed?
The extent of competition for SPE2DR26F3TAZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award